The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: A double-blind laboratory setting study

BJU International

Volumn 107, Issue 8, 2011, Pages 1274-1277

  Gökçe, Ahmet ^a   Halis, Fikret ^a   Demirtas, Abdullah ^a   Ekmekcioglu, Oguz ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

ejaculation latency time; ejaculatory disorder; lifelong premature ejaculation; phosphodiesterase type 5 inhibitor

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; AUDITORY STIMULATION; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PENIS ERECTION; PREMATURE EJACULATION; PRIORITY JOURNAL; REVIEW; SEXUAL AROUSAL; TREATMENT DURATION; VISUAL STIMULATION;

ADMINISTRATION, ORAL; ADULT; CARBOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EJACULATION; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFONES; TREATMENT OUTCOME; TRIAZINES; YOUNG ADULT;

EID: 79954510705     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09646.x     Document Type: Review

References (19)

1. Coolen LM, Allard J, Truitt WA, McKenna KE,. Central regulation of ejaculation. Physiol Behav 2004; 83: 203-15 (Pubitemid 39361566)
2. Jannini EA, Lombardo F, Lenzi A,. Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005; 28 (Suppl. 2): 40-5 (Pubitemid 41719772)
3. Cooper AJ, Cernovsky ZZ, Colussi K,. Some clinical and psychometric characteristics of primary and secondary premature ejaculators. J Sex Marital Ther 1993; 19: 276-88 (Pubitemid 24020777)
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Text Revision. Washington, DC: American Psychiatric Association, 2000
5. McMahon CG, Althof S, Waldinger MD, et al,. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. Br J Urol 2008; 102: 338-50 (Pubitemid 352019206)
6. Giuliano F, Hellstrom WJ,. The pharmacological treatment of premature ejaculation. Br J Urol 2008; 102: 668-75
7. Gökçe A, Demirtas A, Halis F, Ekmekcioglu O,. The effects of phosphodresterase type 5/variables during a period with no inhibitors on penile rigidity sexual stimulation: a laboratory setting double-blind study. BJU Int 2010; doi:10.1111/j.1464-410X. 2010.09390.x
8. Hatzimouratidis K, Hatzichristou D,. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007; 51: 75-88
9. McMahon CG, McMahon CN, Leow LJ, Winestock CG,. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. Br J Urol 2006; 98: 259-72
10. Aversa A, Pili M, Francomano D, et al,. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 2009; 21: 221-7
11. Mathers MJ, Klotz T, Roth S, Lummen G, Sommer F,. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study. Andrologia 2009; 41: 169-75
12. Gökçe A, Demirtas A, Halis F, Ekmekcioglu O,. In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: placebo controlled, double-blind, cross-over laboratory setting. Int Urol Nephrol 2010; Epub ahead of print. DOI: 10.1007/s11255-010-9710-2
13. Mattos RM, Marmo Lucon A, Srougi M,. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008; 80: 162-5 (Pubitemid 351440510)
14. Abdel-Hamid IA, El Naggar EA, El Gilany AH,. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001; 13: 41-5 (Pubitemid 32274649)
15. Ekmekcioglu O, Inci M, Demirci D, Tatlisen A,. Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study. Urology 2005; 65: 347-52 (Pubitemid 40248026)
16. Mondaini N, Ponchietti R, Muir GH, et al,. Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res 2003; 15: 225-8 (Pubitemid 36928916)
17. Waldinger MD, Hengeveld MW, Zwinderman AH,. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 151: 1377-9 (Pubitemid 24281766)
18. Waldinger MD,. Four measures of investigating ejaculatory performance. J Sex Med 2007; 4: 520 (Pubitemid 46394728)
19. Rowland DL, Slob AK,. Vibrotactile stimulation enhances sexual response in sexually functional men: a study using concomitant measures of erection. Arch Sex Behav 1992; 21: 387-400